| REVIEW ARTICLE |
|
| Year : 2017 | Volume
: 6
| Issue : 1 | Page : 1-5 |
|
|
Hypertriglyceridemia–induced acute pancreatitis: A systematic review of the literature
Ionut Negoi1, Sorin Paun1, Massimo Sartelli2, Fausto Catena3, Luca Ansaloni4, Ruxandra Irina Negoi5, Mircea Beuran1
1 General Surgery Department, Emergency Hospital of Bucharest, Carol Davila University of Medicine and Pharmacy Bucharest, Bucharest, Romania
2 Department of Surgery, Macerata Hospital, Via Santa Lucia 2, 62019, Macerata, Italy
3 Department of Surgery, Maggiore Hospital, Parma, Italy
4 General Surgery Department, Papa Giovanni XXIII Hospital, Bergamo, Italy
5 Anatomy Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Correspondence Address:
Ionut Negoi
Senior Lecturer of Surgery, General Surgery Department, Emergency Hospital of Bucharest, Carol Davila University of Medicine and Pharmacy Bucharest, Bucharest
Romania
 Source of Support: None, Conflict of Interest: None
DOI: 10.12980/jad.6.2017JADWEB-2016-0058
|
|
|
Objective: To summarize the current evidence about the hypertriglyceridemia–induced acute pancreatitis (HAP).
Methods: Systematic review of the English language literature was conducted using PubMed/ Medline database from its inception until August 2016. As a searching methodology, we have used a combination of ‘acute pancreatitis’ and ‘hypertriglyceridemia’ as keywords into the title.
Results: The diagnosis of HAP should be based on two out of the three criteria recommended by the international guidelines: characteristic clinical picture, serum pancreatic enzymes, and appropriate imagistics. The diagnosis of HAP should be distinguished between mild hypertriglyceridemia (> 150 mg/dL), which accompanies around one-third of all-causes acute pancreatitis, and severe hypertriglyceridemia (> 1 000 mg/dL) which generates acute pancreatitis. There is mixed evidence regarding a worse prognosis for patients with HAP, and a clear conclusion cannot be drawn. Similar to all the other etiologies, in HAP the initial treatment efforts should be nonspecific and addressed to acute pancreatitis, while pharmacologic and mechanical techniques should be added to lower the serum triglycerides as soon as possible.
Conclusions: We may conclude that HAP should be managed to respect all the general principles, also adding all the available resources to lower the serum triglycerides value, as early as possible in the acute setting and on long-term to prevent recurrences.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
